DanielBRosenbluthMD
Pulmonology • Saint Louis, MOCritical Care Medicine, Cystic Fibrosis, Interventional Pulmonology, Pleural Disease
Tracey C. and William J. Marshall Professor of Medicine, Washington University School of Medicine, St Louis, MO
Dr. Rosenbluth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 314-454-8917Fax+1 314-454-7524
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 1992 - 1995
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1989 - 1992
Icahn School of Medicine at Mount SinaiClass of 1989
Certifications & Licensure
IL State Medical License 1991 - 2026
MO State Medical License 1994 - 2026- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Clinical Trials
- Study to Evaluate Safety and Efficacy of VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation With an Open-Label Expansion Start of enrollment: 2014 Mar 01
- Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF) Start of enrollment: 2014 Aug 01
- Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation Start of enrollment: 2015 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 49 citationsDiscontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multic...Nicole Mayer-Hamblett, Felix Ratjen, Renee Russell, Scott H Donaldson, Kristin A Riekert
The Lancet. Respiratory Medicine. 2023-04-01 - 5 citationsRiociguat for the treatment of Phe508del homozygous adults with cystic fibrosis.Nico Derichs, Jennifer L. Taylor-Cousar, Jane C. Davies, Isabelle Fajac, Elizabeth Tullis
Journal of Cystic Fibrosis. 2021-08-19 - 37 citationsEvaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design.Nicole Mayer-Hamblett, David P. Nichols, Katherine Odem-Davis, Kristin A. Riekert, Greg S. Sawicki
Annals of the American Thoracic Society. 2021-07-30
Press Mentions
List of Temporary Practice Permits Granted May 5, 2020May 5th, 2020
New Drug Appears to Slow Effects of Cystic Fibrosis, Offering Hope to Long-Suffering PatientsDecember 18th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
